Recipharm’s new analytical lab brings impressive testing capabilities to global markets
Global contract development and manufacturing organisation (CDMO) Recipharm has opened a new analytical lab in Bengaluru, India to enhance its global testing capabilities for nitrosamines, extractables and leachables, and elemental impurity testing. Fully cGMP/cGLP compliant, the 5,000 sq.ft lab will expand Recipharm’s existing analytical capabilities and provide support for biotech and pharma customers in their research and development of oral solids, drug delivery, inhalation, vaccines and injectables. The investment in the new lab responds to the increasing demand for a trusted